Evidence map›Paper›PMID 25695747›Full record

ArticlePloS one2015

Analysis of the Campylobacter jejuni genome by SMRT DNA sequencing identifies restriction-modification motifs.

Jason L O'Loughlin, Tyson P Eucker, Juan D Chavez, Derrick R Samuelson, Jason Neal-McKinney, Christopher R Gourley, James E Bruce, Michael E Konkel

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Natural Competence and Horizontal Gene Transfer in Campylobacter.Current topics in microbiology and immunology · 2021
    Article
  4. Article
  5. Review
  6. Article
  7. Comparative Methylome Analysis ofFrontiers in microbiology · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Methylation-dependent DNA discrimination in natural transformation ofProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jason L O'LoughlinSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America.
Tyson P EuckerSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America.
Juan D ChavezDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.
Derrick R SamuelsonSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America.
Jason Neal-McKinneySchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America.
Christopher R GourleySchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America.
James E BruceDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America.
Michael E KonkelSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America.
Washington State University · USUniversity of Washington · US

Funding

TRAINING IN BIOTECHNOLOGY: EMPHASIS ON PROTEIN CHEMISTRYT32GM008336 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CALL, DOUGLAS R. · 1989 to 2023
$8.9M
Infectious Diseases and Microbial Immunology Training ProgramT32AI007025 · NIAID · WASHINGTON STATE UNIVERSITY · PI Thomas H KAWULA, M KARIUKI NJENGA · 1985 to 2026
$7.4M
Quantitation of protein interactions in cancer cellsR01GM086688 · NIGMS · UNIVERSITY OF WASHINGTON · PI BRUCE, JAMES EDWARD · 2009 to 2019
$4.2M
Molecular Bioscience Graduate Training ProgramT32GM083864 · NIGMS · WASHINGTON STATE UNIVERSITY · PI NILSON, JOHN H. · 2010 to 2014
$646k
Molecular mechanisms underlying Campylobacter jejuni cellular invasionR56AI088518 · NIAID · WASHINGTON STATE UNIVERSITY · PI KONKEL, MICHAEL E · 2011 to 2011
$324k
NIAID NIH HHS 5 T32 AI 7025-33NIAID NIH HHS R56 AI088518NIAID NIH HHS R56 AI088518-01A1NIAID NIH HHS T32 AI007025NIGMS NIH HHS 5R01GM086688NIGMS NIH HHS R01 GM086688NIGMS NIH HHS T32 GM008336NIGMS NIH HHS T32GM008336NIGMS NIH HHS T32 GM083864NIGMS NIH HHS T32GM083864
6 · The paper itself

Abstract

Campylobacter jejuni is a leading bacterial cause of human gastroenteritis. The goal of this study was to analyze the C. jejuni F38011 strain, recovered from an individual with severe enteritis, at a genomic and proteomic level to gain insight into microbial processes. The C. jejuni F38011 genome is comprised of 1,691,939 bp, with a mol.% (G+C) content of 30.5%. PacBio sequencing coupled with REBASE analysis was used to predict C. jejuni F38011 genomic sites and enzymes that may be involved in DNA restriction-modification. A total of five putative methylation motifs were identified as well as the C. jejuni enzymes that could be responsible for the modifications. Peptides corresponding to the deduced amino acid sequence of the C. jejuni enzymes were identified using proteomics. This work sets the stage for studies to dissect the precise functions of the C. jejuni putative restriction-modification enzymes. Taken together, the data generated in this study contributes to our knowledge of the genomic content, methylation profile, and encoding capacity of C. jejuni.

Indexed as

Genome, BacterialNucleotide MotifsAlgorithmsBinding SitesCampylobacter jejuniDNA Restriction-Modification EnzymesSequence Analysis, DNADNA Restriction-Modification Enzymes

Identifiers

PMID25695747
PMCPMC4335053
OpenAlexW2110038994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.